Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Study of Palliative Treatment With Nimotuzumab as a Second, Third Line or More of Treatment for Advanced or Metastatic Cervical Cancer

NCT02095119 is registered in ClinicalTrials.gov with National Institute of Cancerología as lead sponsor.

NCT NCT02095119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02095119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Study of Palliative Treatment With Nimotuzumab as a Second, Third Line or More of Treatment for Advanced or Metastatic Cervical Cancer
Lead sponsor
National Institute of Cancerología
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2008
Completion date
March 31, 2014
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uterine cervical cancer